Vaccine development involves a large number of tests to support vaccine research and development (R&D), ranging from early, pre-clinical studies to final production, quality control, and release of batches. ELISA based assays are widely used to measure vaccine titer, vector titer, purity, affinity, and potency, as well as immunogenic response in both animals and humans.